EP 2988681 A1 20160302 - GEL-FORMING SYSTEM FOR REMOVING URINARY CALCULI AND FRAGMENTS THEREOF
Title (en)
GEL-FORMING SYSTEM FOR REMOVING URINARY CALCULI AND FRAGMENTS THEREOF
Title (de)
GELBILDENDES SYSTEM ZUM ENTFERNEN VON HARNSTEINEN UND HARNSTEINFRAGMENTEN
Title (fr)
SYSTÈME GÉLIFIANT POUR ÉLIMINER DES CALCULS URINAIRES ET DES FRAGMENTS DE CALCULS URINAIRES
Publication
Application
Priority
- EP 13164955 A 20130423
- EP 2013067434 W 20130822
- EP 13756034 A 20130822
Abstract (en)
[origin: CA2910201A1] Described primarily are gel-forming systems consisting of or comprising a composition (A), comprising one or more cationically crosslinkable polymers, and a composition (B), comprising one or more crosslinking agents for crosslinking the cationically crosslinkable polymer(s), for use in a method for removing urinary calculi and/or fragments thereof, more particularly kidney stones and/or fragments thereof, from a region of the urinary tract, more particularly a kidney, that contains urinary calculi and/or fragments thereof, more particularly kidney stones and/or fragments thereof, that are to be removed, comprising the following steps: (i) providing the compositions (A) and (B), (ii) introducing the compositions (A) and (B) into a region of the urinary tract, more particularly the kidney, that contains urinary calculi and/or fragments thereof, more particularly kidney stones and/or fragments thereof, that are to be removed, under conditions enabling crosslinking of the cationically crosslinkable polymer(s) on contact between compositions (A) and (B), to form a crosslinked gel that partly or fully surrounds the urinary calculi and/or fragments thereof, more particularly kidney stones and/or fragments thereof, that are to be removed, (iii) removing the crosslinked gel together with the urinary calculi and/or fragments thereof, more particularly kidney stones and/or fragments thereof, that are surrounded with it from the urinary tract, more particularly the kidney.
IPC 8 full level
A61B 17/22 (2006.01); A61K 47/36 (2006.01); A61L 24/00 (2006.01); A61L 24/04 (2006.01)
CPC (source: EP KR US)
A61B 17/22 (2013.01 - KR); A61L 24/0031 (2013.01 - EP KR US); A61L 24/02 (2013.01 - US); A61L 24/04 (2013.01 - EP KR US); A61L 24/08 (2013.01 - US); A61P 13/04 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61B 17/22 (2013.01 - EP US); A61B 2017/00876 (2013.01 - EP KR US); A61B 2017/22082 (2013.01 - US); A61L 2430/26 (2013.01 - EP KR US)
Citation (search report)
See references of WO 2014173467A1
Citation (examination)
- WO 2008042756 A2 20080410 - PLUROMED INC [US], et al
- WO 2006119009 A1 20061109 - PLUROMED INC [US], et al
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 2796100 A1 20141029; EP 2796100 B1 20160420; AU 2013387206 A1 20151112; AU 2013387206 B2 20190124; CA 2910201 A1 20141030; CA 2910201 C 20200324; CN 105491966 A 20160413; CN 105491966 B 20180626; DK 2796100 T3 20160801; EP 2988681 A1 20160302; ES 2577102 T3 20160713; JP 2016519957 A 20160711; KR 20160004321 A 20160112; KR 20200040931 A 20200420; PL 2796100 T3 20160831; US 10232079 B2 20190319; US 2016067373 A1 20160310; WO 2014173467 A1 20141030
DOCDB simple family (application)
EP 13164955 A 20130423; AU 2013387206 A 20130822; CA 2910201 A 20130822; CN 201380077477 A 20130822; DK 13164955 T 20130423; EP 13756034 A 20130822; EP 2013067434 W 20130822; ES 13164955 T 20130423; JP 2016509309 A 20130822; KR 20157033270 A 20130822; KR 20207010523 A 20130822; PL 13164955 T 20130423; US 201314786810 A 20130822